651 related articles for article (PubMed ID: 8625316)
1. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
[TBL] [Abstract][Full Text] [Related]
3. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
4. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
[TBL] [Abstract][Full Text] [Related]
5. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
6. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
7. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
8. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
9. Transforming and c-fos promoter/enhancer-stimulating activities of a GDP/GTP exchange protein for small GTP-binding proteins.
Takai Y; Kaibuchi K; Kikuchi A; Kawata M; Sasaki T; Yamamoto T
Princess Takamatsu Symp; 1991; 22():197-204. PubMed ID: 1844241
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Ral GDP dissociation stimulator-like (RGL) activities to regulate c-fos promoter and the GDP/GTP exchange of Ral.
Murai H; Ikeda M; Kishida S; Ishida O; Okazaki-Kishida M; Matsuura Y; Kikuchi A
J Biol Chem; 1997 Apr; 272(16):10483-90. PubMed ID: 9099691
[TBL] [Abstract][Full Text] [Related]
11. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
12. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
Frankel P; Ramos M; Flom J; Bychenok S; Joseph T; Kerkhoff E; Rapp UR; Feig LA; Foster DA
Biochem Biophys Res Commun; 1999 Feb; 255(2):502-7. PubMed ID: 10049738
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
Marshall M
Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
[TBL] [Abstract][Full Text] [Related]
14. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
15. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
[TBL] [Abstract][Full Text] [Related]
16. Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.
Sonoda H; Nishida K; Yoshioka T; Ohtani M; Sugita K
Oncogene; 1996 Jul; 13(1):143-9. PubMed ID: 8700540
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes.
Reed JC; Yum S; Cuddy MP; Turner BC; Rapp UR
Cell Growth Differ; 1991 May; 2(5):235-43. PubMed ID: 1888699
[TBL] [Abstract][Full Text] [Related]
18. Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1.
Zhang Y; Saez R; Leal MA; Chan AM
Oncogene; 1996 Jun; 12(11):2377-83. PubMed ID: 8649778
[TBL] [Abstract][Full Text] [Related]
19. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
20. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]